Prevalence of autoimunne thyroid diseases in women with breast cancer in comparison with colorectal cancer;Prevalence autoimunitních tyreopatií u žen s karcinomem prsu ve srovnání s kolorektálním karcinomem

Klinicka Onkologie

Volumn 16, Issue 3, 2003, Pages 149-153

  Jiskra, J ^a   Limanova Z ^a   Barkmanova J ^a   Friedmannova Z ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Breast cancer; Thyroid autoantibodies; Thyroid stimulating hormone

Indexed keywords

CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; ENZYME ANTIBODY; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE; THYROTROPIN; THYROXINE; TUMOR MARKER;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BREAST CANCER; CANCER STAGING; CHEMOLUMINESCENCE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FREE THYROXINE INDEX; HASHIMOTO DISEASE; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; SURVIVAL RATE; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

EID: 0042524220     PISSN: 0862495X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Smyth P.P., Smith D.F., McDermott E.W., Murray M.J., Geraghty J.G., OHiggins N.J.: A direct relationship between thyroid enlargement and breast cancer. J. Clin. Endocrinol. Metab., 81, 1996, 937-941.
2. Shering S.G., Zbar A.P., Moriarty M., Mcdermott E.W., O'Higgins N.J., Smyth P.P.: Thyroid disorders and breeeast cancer. Eur. J. Cancer Prev., 6, 1996, 504-506.
3. Smyth P.P., Shering S.G., Kilbane M.T., Murray M.J., McDermot E.W., Smith D.F., O'Higgins N.J.: Serum thyroid peroxidase autoantibodies, thyroid volume, and outcome in breast cancer. J. Clin. Enocrinol. Metab., 83, 1998, 2711-2716.
4. Limanová Z., Barkmanová J., Friedmannová Z., Kašparová E., Tichá, Spanlangová I., Jelínková A.: Thyroid gland function in women with breast carcinoma. Vnitřní Lékařství, 42, 1996, 605-609.
5. Límanová Z., Barkmanová J., Friedmanová Z.: The frequent incidence of thyreopaties in women with breast carcinoma. Vnitřní Lékařství, 44, 1998, 76-82.
6. Mizia-Stech K., Zych F., Widala E.: Mastopathy and simple goiter-mutual ralationship. Przegl. Lek., 55, 1998, 250-258.
7. Zych F., Mizia Stec K., Mucha Z., Zych F., Twardowska E.: Fibrocystic disease of breast and pituitary axis function. Pol. Merkurius Lek., 1, 1996, 227-228.
8. Goldman M.B., Monson A.A., Maloof F.: Benign thyroid disease and risk of death from breast cancer. Oncology 49, 1992, 461-466.
9. Shering S.G., Kilbane M.T., Smith D.F. et al.: Thyroid autoimmunity - a positive prognostic factor in breast cancer. Journal of Endocrinology, 151, 1997, 106.
10. Gogas J., Kouskos E., Tseleni-Balafouta S., Markopoulos C., Revenas K., Gogas G., Kostakis A.: Autoimmune thyroid disease in women with breast carcinoma. Eur. J. Surg. Oncol., 27, 2001, 626-630.
11. Dayan C.M., Saravan P., Bayly G.: Whose normal thyroid fuction is better - yours or mine? The Lancet, 3, 2002, 353-354.
12. Mamby C.C., Love R.R., Lee K.E.: Thyroid function test changes with adjuvant tymoxifen therapy postmenopausal women with breast cancer. J. Clin. Oncol., 13, 1995, 854-857.
13. Anker G.B., Lonning P.E., Aakvaag A., Lien E.A.: Thyroid function in postmenopausal breast cancer patients treated with tamoxifen. Scand. J. Clin. Lab. Invest., 58, 1998, 103-107.
14. Zidan J., Rebenstein W.: Effect of adjuvant tamoxifen therapy on thyroid function postmenopausal women with breast cancer. Oncology, 56, 1999, 43-45.
15. Schmutzler C., Kohrle J.: Imlications of the molecular charakterization of the sodium-iodide symporter (NIS). Exp. Clin. Endocrinol. Diabetes, 106, 1998, 1-10.
16. Zamrazil V.: Present status of the iodine supply and its results in the Czech Republic. Cas. Lek. Cesk., 137, 1998, 611-618.
17. Zamrazil V., Cerovska J., Bilek R., Simeckova A., Vrbikova J., Dvorakova M., Hnikova O., Janeckova M., Tomiska F.: The effect of insufficient iodine intake on the size and function of the thyroid gland. Bratisl. Lek. Listy, 96, 1995, 609-612.
18. Smanik P.A., Ryu K.Y., Theil K.S., Mazzaferri E.L., Jhiang S.M.: Expression, exon- intron organisation of the human sodium iodide symporter. Endocrinology, 138, 1997, 3555-3558.
19. Ajjan R.A., Watson P.F., Findlay C., Metcalfe R.A., Crisp M., Ludgate M., Weetman A.P.: The sodium iodide symporter gene and its regulation by cytokines found in autoimmunity. J. Endocrinol., 1558, 1998, 351-358.
20. Filleti S., Bidart J.M., Arturi F., Caillou B., Russo D., Schlumberger M.: Sodium/iodide symporter: a key transport system in the thyroid cancer cell metabolism. Eur. J. Endocrinol., 141, 1999, 443-457.
21. Feldt-Rasmussen U.: Iodine and cancer. Thyroid, 11, 2001, 483-486.
22. Riedel C., Dohan O., De la Vieja A., Ginter C.S., Carrasco N.: Journey of the iodide transporter NIS: from its molecular identification to its clinical role in cancer. Trends Biochem. Sci., 26, 2001, 490-496.
23. Spitzweg C., Joba W., Eisenmenger W., Huefelder A.E.: Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acid from salivary gland, mammary gland and gastric mucosa. J. Clin. Endocrinol. Metab, 83, 1998, 1746-1751.
24. Cho J.Y., Leveille R., Kao R., Rousset B., Parlow A.F., Burak W.E. Jr., Mazzaferri E.L., Jhiang S.M.: Hormonal regulation of radioiodide uptake activity and Na+/I- symporter expression in mammary glands. J. Clin. Endocrinol. Metab., 85, 2000, 2936-2943.
25. Eskin B.A.: Iodine and mammary cancer. Adv. Exp. Med. Biol., 91, 1977, 293-304.
26. Smyth P.P.: The Thyroid and breast cancer: a significant association? Ann. Med., 29, 1997, 189-191.
27. Funahashi H., Imai T., Tanaka Y., Tobinaga J., Wada M., Morita T., Yamada F., Tsukamura K., Oiwa M., Kikumori T., Narita T., Takagi H.: Suppressive effect of iodine on DMBA-induced breast tumor growth in the rat. J. Surg. Oncol., 61, 1996, 209-213.
28. Funahashi H., Imai T., Tanaka Y., Tsukamura K., Hayakawa Y., Kikumori T., Mase T., Itoh T., Nishikawa M., Hayashi H., Shibata A., Hibi Y., Takahashi M., Narita T.: Wakame seaweed suppresse the proliferation of 7,12-dimethylbenz(a)-anthracene-induced mammary tumors in rats. JPN J. Cancer Res., 90, 1999, 922-927.
29. 125I Uptake-Blocking Activity in Breast Cancer. J. Clin. Endocrinol. Metab., 85, 2000, 1245-1250.
30. Yokoe T., Iino Y., Takei H., Horiguchi J., Koibuchi Y., Maemura M., Ohwada S., Morishita Y.: Changes of cytokines and thyroid function in patients with recurrent breast cancer. Anticancer Res., 17, 1997, 695-699.
31. Yokoe T., Iino Y., Takei H., Horiguchi J., Koibuchi Y., Maemura M., Ohwada S., Morishita Y.: Relationship between thyroid pituitary function and respons to therapy in patients with recurrent breast cancer. Anticancer Res., 16, 1996, 2069-2077.